ГоловнаArchive of numbers2019Volume 27, issue 2 (99)Dysfunction of bloodbrain barrier and intrathecal immune response in patients with clinically isolated multiple sclerosis syndrome
Title of the article Dysfunction of bloodbrain barrier and intrathecal immune response in patients with clinically isolated multiple sclerosis syndrome
Authors Shulga Olga
In the section MECHANISMS OF FORMATION AND MODERN PRINCIPLES OF TREATMENT OF NEUROLOGICAL DISORDERS
Year 2019 Issue Volume 27, issue 2 (99) Pages 20-22
Type of article Scientific article Index UDK 616.831-009.81 Index BBK -
Abstract The study is devoted to the evaluation of blood-brain barrier dysfunction and intrathecal synthesis of immunoglobulin G in patients with clinically isolated syndrome (CIS) of multiple sclerosis. The presence of oligoclonal bands and immunoglobulin G indicates an increased risk of multiple sclerosis in patients with CIS, regardless of the presence of other risk factors. An observational study of an intranasal response in patients with CIS was performed for the fi rst time in Ukraine. Based on the evaluation of cerebrospinal fl uid and blood parameters in 19 adult patients, it was found that 68 % of patients had an impairment of permeability of the blood-brain barrier. Synthesis of intrathecal immunoglobulin G is present in two thirds of cases.
Key words clinically isolated syndrome, multiple sclerosis, blood-barrier, intrathecal synthesis, immunoglobulin G
Access to full text version of the article pdf download
Bibliography


1. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria / Thompson A. J., Banwell B. L., Barkhof F. [et al.] // The Lancet Neurology. 2018 Feb; 17(2). P. 162—173. DOI: 10.1016/S1474-4422(17)30470-2.
2. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis / Montalban X, Gold R., Thompson A. J. [et al.] // European Journal of Neurology. 2018. DOI: 10.1111/ene.13536.
3. Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome / Makhani N., Lebrun C., Siva A., [et al.] // Mult Scler J Exp Transl Clin. 2019; 5(1): 055217319836664. DOI:10.1177/2055217319836664.
4. Defining high, medium and low impact prognostic factors for developing multiple sclerosis / Mar Tintore, Alex Rovira, Jordi Rio [et al.] // Brain. 2015. Vol. 138, Issue 7. P. 1863—1874, URL:https://doi.org/10.1093/brain/awv105.
5. Reiber H. Cerebrospinal fluid data compilation and knowledgebased interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases: diagnostic patterns not to be missed in Neurology and Psychiatry // Arq. Neuro-Psiquiatr. 2016. Vol. 74, no. 4. P. 336—49. DOI: 10.1590/0004-282X20160044.
6. Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report / Andersson M., Alvarez-Cermeno J., Bernardi G. [et al] // J. Neurol. Neurosurg. Psychiatry. 1994; 57: 897—902. DOI: 10.1136/jnnp.57.8.897.
7. Ganrot, K., Laurell, C. B. Measurement of IgG and albumin content of cerebrospinal fluid and its interpretation // Clin. Chem. 1974; 20: 571—573. PMID: 4207912.
8. Reiber, H. The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid // J. Neurol. 1980; 224: 89—99. PMID: 6160221.
9. Ganrot-Norlin, K. Relative concentrations of albumin and IgG in cerebrospinal fluid in health and in acute meningitis // Scand. J. Infect. Dis. 1978; 10: 57—60. PMID: 635476.
10. Reiber H, Peter JB. Cerebrospinal fluid analysis: diseaserelated data patterns and evaluation programs // J Neurol Sci. 2001. Vol. 184, Issue 2, P. 101—122. DOI: 10.1016/S0022-510X(00)00501-3.
11. Reiber, H. Evaluation of blood-cerebrospinal fluid barrier dysfunctions in neurological diseases. In: The blood-brain barrier in health and disease / A. J. Suckling, M. G. Rumsby, M. W. B. Bradbury (Eds.). Ellis Horwood, Chichester, UK; 1986:P. 147—157.
12. Laurell, C. B. On the origin of major CSF proteins. In: Advances in CSF protein research and diagnosis / E. J. Thompson (Ed.). MTP Press, Lancaster, UK; 1987: 123—128.
13. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria / C. H. Polman, S. C. Reingold, B. Banwell [et. al.] // Annals of Neurology. 2011. Vol. 69, Issue 2. P. 292—302. DOI: 10.1002/ana.22366